Literature DB >> 15387943

[Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence].

Yu-ming Li1, Shi-xin Wang, Hong-sheng Gao, Jing-gui Wang, Chuan-she Wei, Li-ming Chen, Wu-li Hui, Shu-ling Yuan, Zhen-shan Jiao, Zhen Yang, Bin Su.   

Abstract

OBJECTIVE: To explore the factors affecting the pathogenesis of avascular necrosis of femoral head and osteoporosis of SARS patients during convalescent stage.
METHODS: The clinical data of 40 SARS patients, 12 males and 28 females, aged 29 +/- 9, hospitalized from April to June 2003, were reviewed, targeted on the use of glucocorticoids. Three months after the discharge ELISA and indirect immunofluorescent antibody (IFA) assay were used to detect the serum IgG. Magnetic resonance imaging (MRI) was used to detect the damage of the head of femur and quantitative ultrasound (QUS) was used to detect osteoporosis at the left heel.
RESULTS: The average total dosage of methylprednisolone was (4949 +/- 2959) mg, and the average course of treatment was (24 +/- 5) days (16 to 30 days). Twenty-three patients underwent ictus therapy of corticosteroids for (8 +/- 4) days. The extenuation time of corticosteroid' dosage was (33 +/- 26) mg/d. Of the 40 patients, 36 were IgG positive with an average A value of (0.91 +/- 0.24) and 4 patients were IgG negative. Twelve patients (30%) were with type I avascular necrosis of femoral head, including 3 cases with unilateral left--necrosis and 9 cases of bilateral necrosis. The other 28 patients were without necrosis. Two patients were suffering from osteoporosis and 30 patients were with bone density decrement. The average Z values of the parameter BUA and VOS were (-1.26 +/- 0. 53) and (-0.53 +/- 0.30) respectively. The corresponding T values of the parameter BUA and VOS were (-1.49 +/- 0.59) and (-0.65 +/- 0.05) respectively. The influencing factors of femoral necrosis included the degree of healing activity, the dosage summation of corticosteroids, and length of ictus therapy. The influencing factors of bone density included age, dosage summation, and length of ictus therapy. The influencing factors of the bone fabric and flexibility included the use and length of ictus therapy. Statistics showed that serum IgG was not related with avascular necrosis of femoral head and osteoporosis.
CONCLUSIONS: The incidence rates of avascular necrosis of femoral head and of osteoporosis were higher in convalescent SARS patients than in general population. The influencing factors of femoral necrosis included the degree of healing activity, the dosage summation of corticosteroids, and length of ictus therapy. The influencing factors of bone density included age, dosage summation, and length of ictus therapy. The influencing factors of the bone fabric and flexibility included the use and length of ictus therapy. Statistics showed that serum IgG was not related with avascular necrosis of femoral head and osteoporosis. SARS virus may not affect the pathogenesis of avascular necrosis of femoral head and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15387943

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  27 in total

Review 1.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 2.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 3.  SARS: systematic review of treatment effects.

Authors:  Lauren J Stockman; Richard Bellamy; Paul Garner
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

4.  Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge.

Authors:  Lixin Xie; Youning Liu; Baoxing Fan; Yueyong Xiao; Qing Tian; Liangan Chen; Hong Zhao; Weijun Chen
Journal:  Respir Res       Date:  2005-01-08

5.  Considerations for Postacute Rehabilitation for Survivors of COVID-19.

Authors:  Lisa Mary Sheehy
Journal:  JMIR Public Health Surveill       Date:  2020-05-08

6.  Efficacy of Corticosteroids in Patients with SARS, MERS and COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Keum Hwa Lee; Sojung Yoon; Gwang Hun Jeong; Jong Yeob Kim; Young Joo Han; Sung Hwi Hong; Seohyun Ryu; Jae Seok Kim; Jun Young Lee; Jae Won Yang; Jinhee Lee; Marco Solmi; Ai Koyanagi; Elena Dragioti; Louis Jacob; Joaquim Radua; Lee Smith; Hans Oh; Kalthoum Tizaoui; Sarah Cargnin; Salvatore Terrazzino; Ramy Abou Ghayda; Andreas Kronbichler; Jae Il Shin
Journal:  J Clin Med       Date:  2020-07-27       Impact factor: 4.241

7.  Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.

Authors:  Rong-Chang Chen; Xiao-Ping Tang; Shou-Yong Tan; Bi-Ling Liang; Zhuo-Yue Wan; Ji-Qian Fang; Nanshan Zhong
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

8.  Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study.

Authors:  Shixin Wang; Maoti Wei; Yi Han; Keju Zhang; Li He; Zhen Yang; Bing Su; Zhilun Zhang; Yilan Hu; Wuli Hui
Journal:  BMC Infect Dis       Date:  2008-02-29       Impact factor: 3.090

9.  Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study.

Authors:  Xia Hong; Glenn W Currier; Xiaohui Zhao; Yinan Jiang; Wei Zhou; Jing Wei
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

Review 10.  Controversial treatments: An updated understanding of the coronavirus disease 2019.

Authors:  Cantong Zhang; Shaoying Huang; Fengping Zheng; Yong Dai
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.